This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Société Française de Pharmacologie et de Thérapeutique | |
|---|---|
| Name | Société Française de Pharmacologie et de Thérapeutique |
| Abbreviation | SFPT |
| Formation | 1937 |
| Headquarters | Paris |
| Region served | France |
| Language | French |
| Leader title | President |
Société Française de Pharmacologie et de Thérapeutique is a learned society devoted to pharmacology and therapeutics in France, founded to foster research, education, and clinical translation across academic, industrial, and regulatory sectors. It engages with national and international institutions to promote drug discovery, safety, and policy, and organizes meetings, publications, and training for scientists, clinicians, and regulators.
The society was established in the context of interwar scientific reorganization alongside institutions such as the Institut Pasteur, Collège de France, Académie des Sciences, Université de Paris, and Centre national de la recherche scientifique. Early interactions involved figures connected with Louis Pasteur, Alexandre Yersin, Emile Roux, Jean Hamburger, and later contributors associated with Institut Curie and Hôpital Saint-Antoine. Throughout the postwar era the society engaged with bodies like Organisation mondiale de la santé, European Medicines Agency, Organisation for Economic Co-operation and Development, and Conseil de l'Europe while paralleling developments at Université Paris Descartes and Université de Strasbourg. During the late 20th century links expanded to pharmaceutical companies such as Sanofi, Roche, Pfizer, Novartis, and collaborations with research centers like Institut national de la santé et de la recherche médicale and INSERM.
The society’s mission aligns with priorities of bodies including Ministère des Solidarités et de la Santé, Agence nationale de sécurité du médicament et des produits de santé, European Commission, World Health Organization, and European Federation of Pharmaceutical Industries and Associations. Activities include organizing scientific sessions comparable to those of American Society for Pharmacology and Experimental Therapeutics, British Pharmacological Society, and International Union of Basic and Clinical Pharmacology, providing guidance on drug safety akin to Council for International Organizations of Medical Sciences, and contributing to public debates involving Haute Autorité de Santé and Conseil économique, social et environnemental.
Governance comprises an executive board with roles analogous to governance in Université de Lyon, Université de Bordeaux, and Université de Montpellier faculties, and committees mirrored in organizations such as European Society of Clinical Pharmacology and Therapeutics and International Society for Pharmacoeconomics and Outcomes Research. The society interfaces with regulatory committees at Agence européenne des médicaments and scientific advisory groups at INSERM and university hospitals including Hôpital de la Salpêtrière, Hôpital Beaujon, and Hôpital Bicêtre.
Membership draws researchers, clinicians, and industry scientists from institutions like CNRS, INSERM, Sorbonne Université, École Normale Supérieure, and firms such as Sanofi and Servier. Training programs, workshops, and summer schools are offered in collaboration with entities such as European Medicines Agency, Council of Europe, Institut Pasteur, and university departments at Université Grenoble Alpes and Université Claude Bernard Lyon 1, often featuring speakers from National Institutes of Health, Karolinska Institutet, Massachusetts Institute of Technology, and University of Oxford.
Annual and thematic meetings are comparable to conferences organized by American College of Clinical Pharmacology, British Pharmacological Society, and European Society for Clinical Investigation, and frequently hosted in venues such as Palais des Congrès de Paris and university auditoria at Université de Strasbourg. Publications and proceedings link to journals and publishers like Nature, Science, The Lancet, British Medical Journal, European Journal of Pharmacology, and scientific committees connected to INSERM and CNRS.
Research priorities span areas studied at Institut Pasteur, College de France, and laboratories affiliated with Inserm Unit 1016 and CNRS Unit 8105, including mechanistic studies resembling work from Max Planck Society, translational research in partnership with European Molecular Biology Laboratory, and clinical trials coordinated with Agence nationale de sécurité du médicament et des produits de santé and hospital networks like Assistance Publique–Hôpitaux de Paris. International collaborations include projects with European Commission Horizon 2020, World Health Organization, NIH, Wellcome Trust, and networks such as European Clinical Research Infrastructure Network.
The society confers awards and honors analogous to prizes administered by Académie des Sciences, Léopold Escande Prize, and distinctions in partnership with universities including Université de Paris-Saclay and institutions like Institut Pasteur. Recipients have included investigators affiliated with INSERM, CNRS, Sorbonne Université, Université de Lyon, and international laureates associated with Nobel Prize winners and notable awardees from European Research Council grants.
Category:Pharmacology organizations Category:Medical societies based in France